GS
60
-13
RRC
36
-12
TJX
46
7
QCOM
62
5
SWK
39
2
HD
34
3
AEE
71
3
VZ
40
8
AIG
53
2
KR
68
3
AFL
44
-4
EIX
48
9
REGN
40
2
PX
69
-4
PH
56
-6
SBUX
37
-2
AMG
71
-4
BF.B
46
-4
UA
38
3
MDLZ
57
-2
GS
60
-13
RRC
36
-12
TJX
46
7
QCOM
62
5
SWK
39
2
HD
34
3
AEE
71
3
VZ
40
8
AIG
53
2
KR
68
3
AFL
44
-4
EIX
48
9
REGN
40
2
PX
69
-4
PH
56
-6
SBUX
37
-2
AMG
71
-4
BF.B
46
-4
UA
38
3
MDLZ
57
-2
Financhill
Back

Q2 Holdings Vs. Blueprint Medicines Industry Stock Comparison

Sell
47

QTWO
Q2 Holdings

Last Price:
$89.96
Seasonality Move:
-3.58%
Buy
53

BPMC
Blueprint Medicines

Last Price:
$129.46
Seasonality Move:
1.87%
Sell
47
Q2 Holdings (QTWO) is a Sell

Is Q2 Holdings a Buy, Sell or Hold?

  • The current Q2 Holdings [QTWO] share price is $89.95. The Score for QTWO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • QTWO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

QTWO Stock Price Chart

What is Q2 Holdings's stock price today?

  • The Q2 Holdings share price today is $89.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QTWO is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $129.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

QTWO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 24.86 Buy
Relative Strength Index (14 RSI): 47.45 Sell
Chaikin Money Flow: -297677 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.73 - 94.13) Sell
Bollinger Bands (100): (77.46 - 91.36) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.49 Buy
Relative Strength Index (14 RSI): 76.66 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (128.07 - 129.15) Buy
Bollinger Bands (100): (85.79 - 122.45) Buy

QTWO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.48 Sell
20-day SMA: 92.44 Sell
50-day SMA: 90.44 Sell
200-day SMA: 89.43 Buy
8-day EMA: 83.33 Buy
20-day EMA: 57.53 Buy
50-day EMA: 30.05 Buy
200-day EMA: 8.68 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 129.38 Buy
20-day SMA: 128.73 Buy
50-day SMA: 119.37 Buy
200-day SMA: 99.85 Buy
8-day EMA: 129.26 Buy
20-day EMA: 127.9 Buy
50-day EMA: 120.09 Buy
200-day EMA: 103.72 Buy

Q2 Holdings Earnings Growth & QTWO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.06 per share, an increase this year of $0.59 per share, and an increase next year of $0.33 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.

Q2 Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):